ARCHIVES

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

This article is from The Cancer Letter archive.

Vol. 36 No. 01 | January 15, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

Board Commends M.D. Anderson On 50th Year

May 17, 1991

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990

Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance”

October 19, 2012